Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3?7 hours. Long-acting formulations also exist. The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S. The global Medical Morphine market is valued at 11000 million US$ in 2018 and will reach 13100 million US$ by the end of 2025, growing at a CAGR of 2.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Medical Morphine market based on company, product type, end user and key regions. This report studies the global market size of Medical Morphine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Medical Morphine in these regions. This research report categorizes the global Medical Morphine market by top players/brands, region, type and end user. This report also studies the global Medical Morphine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Mallinckrodt Pharmaceuticals Alcaliber Purdue Pharma Pfizer Sun Pharmaceutical Industries Taj Pharmaceuticals Limited Market size by Product Oral Injectables Market size by End User Cancer Arthritis Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Medical Morphine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Medical Morphine market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Medical Morphine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Medical Morphine submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Medical Morphine are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Medical Morphine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Medical Morphine Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Medical Morphine Market Size Growth Rate by Product 1.4.2 Oral 1.4.3 Injectables 1.5 Market by End User 1.5.1 Global Medical Morphine Market Size Growth Rate by End User 1.5.2 Canc
